Probing the glioma micro-environment: Analysis using biopsy in combination with ultra-fast cyclic immunolabeling

Thomas S van Solinge1, Juhyun Oh2, Erik Abels3

  • 1Departments of Neurology and Radiology, Massachusetts General Hospital, and Program in Neuroscience, Harvard Medical School, Boston, MA, USA; Department of Neurosurgery, Leiden University Medical Center, Leiden, the Netherlands.

Neoplasia (New York, N.Y.)
|September 13, 2024
PubMed

Insights

Researchers developed a repeat-biopsy model in mice to track immune changes in brain tumors (gliomas) over time. This method allows safe, repeated cell collection for studying glioma immunology and treatment responses.

Area of Science:

  • Neuro-oncology
  • Immunology
  • Translational Medicine

Background:

  • The glioma-immune system interaction is poorly understood, impeding effective immunotherapy development.
  • Tumor-induced immune responses are dynamic and influenced by treatments like surgery, radiation, and chemotherapy.
  • Assessing these local immune changes is challenging due to tumor inaccessibility and invasive sampling methods.

Purpose of the Study:

  • To establish a novel mouse model for repeated, minimally invasive sampling of intracranial tumors.
  • To longitudinally investigate dynamic immunological changes within gliomas over time and in response to therapy.
  • To enable detailed analysis of the tumor microenvironment's immune landscape in individual animals.

Main Methods:

  • Development of a fine needle biopsy technique for safe, repeated cell collection from murine intracranial tumors.
  • Application of ultra-fast cycling (FAST) technology for multi-cycle immunofluorescence staining of retrieved cells.
  • Integration of repeat-biopsy and FAST immunofluorescence for longitudinal immune profiling.

Main Results:

  • Demonstrated the feasibility of safely and repeatedly collecting viable cells from intracranial tumors via fine needle biopsy.
  • Utilized FAST immunofluorescence to analyze cellular immune changes over time within the same animal.
  • Provided insights into the dynamic immune response during glioma development and potentially in response to treatment.

Conclusions:

  • The developed repeat-biopsy model combined with FAST immunofluorescence is a powerful tool for studying glioma immunology.
  • This approach overcomes limitations of single-time-point sampling, allowing detailed longitudinal analysis of the immune response.
  • The methodology can be applied to gliomas and other intracranial diseases to advance understanding and therapeutic strategies.

Related Concept Videos